New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

Virtus LifeSci Biotech Clinical Trials ETF

This ETF provides exposure to Equally Weighted US Equities

BBC performance and flow charts

Last update 10/27/2026 at 1:30 PM
Live
Closed
Last price
$42.87
+$1.81 (+4.40%) Yesterday

Performance

-15.0-10.0-5.00.0%Sep 28Oct 5Oct 12Oct 19Oct 26

Flows

0
1 day price range
$41.18
$42.87
52 week price range
$29.82
$55.94
1W perf
+0.48%
YTD perf
+10.70%
YTD flows
+$5M
AuM
$41M
E/R
0.65%
TTM yield
1.53%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of October 27, 2026
1M3MYTD1Y3Y5Y
Perf.-7.04%-13.67%+10.70%+36.99%+160.59%+1.02%
Flows--+$5M+$12M+$16M+$8M
Data as of October 27, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The Virtus LifeSci Biotech Clinical Trials ETF is built to track the LifeSci Biotechnology Clinical Trials Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderVIRTUS Investment Partners
N° of holdings127
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateDecember 16, 2014
ESGNo
TrackinsightTrackinsight

More data and info about BBC on Trackinsight

Exposure

Data as of August 31, 2026

Diversification

17.14%

Total weight of top 15 holdings out of 127

Top 15 Holdings

Amylyx Pharmaceuticals, Inc.
1.5%
First Tracks Biotherapeutics, Inc.
1.48%
AbCellera Biologics, Inc.
1.38%
Xencor, Inc.
1.36%
Monopar Therapeutics, Inc.
1.12%
MBX Biosciences, Inc.
1.11%
uniQure NV
1.09%
Replimune Group, Inc.
1.06%
4D Molecular Therapeutics, Inc.
1.04%
SELLAS Life Sciences Group, Inc.
1.04%
Alto Neuroscience, Inc.
1%
LB Pharmaceuticals, Inc.
1%
Oric Pharmaceuticals, Inc.
0.99%
Zenas BioPharma, Inc.
0.98%
Cullinan Therapeutics, Inc.
0.98%

Sectors

Healthcare
96.27%
Other
3.73%

Countries

USA
87.24%
Other
12.76%
Advertisement

Trading data

Last sale
10/27/2026 at 1:30 PM
$42.87
Previous close
$41.06
Consolidated volume
10/27/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+36.77%+36.97%+37.66%+40.00%
Max drawdown
-29.70%-29.70%-54.25%-70.04%
Max drawdown duration
69d69d340d1625d
Time to recover
N/AN/A193d374d

Replication quality

Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Advertisement
Frequently asked questions about BBC

What type of ETF is BBC?

BBC is a Passive ETF that provides exposure to Equity assets. It is managed by VIRTUS Investment Partners.

What index does BBC track?

BBC tracks the LifeSci Biotechnology Clinical Trials Total Return Index - USD, aiming to replicate its performance through full replication.

What does BBC invest in?

This ETF provides exposure to Equally Weighted US Equities. It is part of the segment: Tomorrow's Treatments.

What is the expense ratio of BBC?

The total expense ratio (TER) of BBC is 0.65%, representing the annual fee charged by the fund manager.

When was BBC launched?

BBC was launched on December 16, 2014, marking its entry into the ETF market.

Who is the issuer of BBC?

BBC is issued by VIRTUS Investment Partners.

What is the AUM of BBC?

As of October 27, 2026, BBC manages $40.68 M, reflecting the total assets held in the fund.

How has BBC performed recently?

As of October 27, 2026, BBC delivered a return of -7.04% over the past month (1M performance), -13.67% over the past three months (3M), and 10.7% year-to-date (YTD).

Does BBC pay dividends?

As of October 27, 2026, BBC has a trailing 12-month distribution yield of 1.53%.

How many holdings are in BBC

As of August 31, 2026, BBC holds 127 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is BBC?

As of August 31, 2026, BBC holds 127 securities, with 17.14% of its assets concentrated in its top 15 holdings.

What are the top holdings of BBC?

As of August 31, 2026, BBC holds a portfolio of 127 underlyings, with its largest positions including Amylyx Pharmaceuticals, Inc., First Tracks Biotherapeutics, Inc. and AbCellera Biologics, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does BBC invest in?

As of August 31, 2026, BBC has its largest geographic exposures in USA.

What sectors or themes does BBC focus on?

As of August 31, 2026, BBC is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

ETF Investing Trends - First Look

First Look ETF

First Look ETF: Income, International, and Cash Flow ETFs

In this season 6 episode of First Look ETF, Stephanie Stanton ‪@etfguide‬ examines the latest ETF marketplace trends with NYSE and guests.

ETF Guide
By ETF Guide · October 20, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs October 5, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · October 6, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 28, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 29, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 22, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 23, 2026

Browse all educational columns

Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026